Lutronic announces R-GEN acquires approval of macular edema treating device
On the 6th, Lutronic(CEO Hae-Ryung Hwang) announced ‘R-GEN’ acquired approval of the world’s first macula treating smart laser from the U.S. FDA. It is the first time for a Korean company to acquire approval of an ophthalmology treating device in the U.S.
The approval is associated with macular...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
